QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：金属研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707 作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi 收藏  |  浏览/下载：33/0  |  提交时间：2021/02/02 RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery   Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707 作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi 收藏  |  浏览/下载：17/0  |  提交时间：2021/02/02 RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery   Design, Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as Potential Antitumor Agents 期刊论文 CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2015, 卷号: 31, 期号: 5, 页码: 746-755 作者:  Hu Hao;  Jiang Mingyan;  Xie Lijun;  Hu Gang;  Zhang Cuirong 收藏  |  浏览/下载：23/0  |  提交时间：2021/02/02 MET KINASE INHIBITORS  GROWTH-FACTOR RECEPTOR  C-MET  6,7-DISUBSTITUTED-4-PHENOXYQUINOLINE DERIVATIVES  BIOLOGICAL EVALUATION  DISCOVERY  MOIETY  BEARING  IDENTIFICATION  4-Phenoxyquinoline derivative  Cytotoxic activity  3-Amino-2-cyano-acrylamide   Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations 期刊论文 ACTA PHARMACOLOGICA SINICA, 2013, 卷号: 34, 期号: 11, 页码: 1475-1483 作者:  Yu Zhe;  Ma Yuchi;  Ai Jing;  Chen Danqi;  Zhao Dongmei 收藏  |  浏览/下载：26/0  |  提交时间：2021/02/02 SULFUR-PI INTERACTIONS  PERTURBATION-THEORY  SUBSTITUENTS  SANDWICH  BENZENE  PATHWAY  receptor tyrosine kinase  type I c-Met inhibitor  cancer  quantum chemistry  protein-ligand interaction  symmetry-adapted perturbation theory (SAPT)   Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations 期刊论文 ACTA PHARMACOLOGICA SINICA, 2013, 卷号: 34, 期号: 11, 页码: 1475-1483 作者:  Yu Zhe;  Ma Yuchi;  Ai Jing;  Chen Danqi;  Zhao Dongmei 收藏  |  浏览/下载：35/0  |  提交时间：2021/02/02 SULFUR-PI INTERACTIONS  PERTURBATION-THEORY  SUBSTITUENTS  SANDWICH  BENZENE  PATHWAY  receptor tyrosine kinase  type I c-Met inhibitor  cancer  quantum chemistry  protein-ligand interaction  symmetry-adapted perturbation theory (SAPT)